The erythropoietin‐derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia
Sandra Palus(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Jochen Springer(University of Göttingen), Tanja Braun(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Stephan von Haehling(German Centre for Cardiovascular Research), Yulia Elkina(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Stefan D. Anker(Charité - Universitätsmedizin Berlin), Anthony Cerami(Araim Pharmaceuticals (United States)), Wolfram Döhner(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Michael Brines(Northwell Health)
Cited by 5
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k